Establishing cost-effectiveness of genetic targeting of cancer therapies

Share/Save/Bookmark

Retèl, Valesca P. and Rutgers, E.J.Th. and Joore, M.A. and Harten van, W.H. (2008) Establishing cost-effectiveness of genetic targeting of cancer therapies. EJHP Practice, 14 (6). pp. 52-54. ISSN 1781-9989

[img]
Preview
PDF
341Kb
Abstract:The clinical benefit of a new genomic instrument, the 70-gene signature
for breast cancer patients, is being evaluated in a randomised clinical
trial. The early, controlled implementation process is supported by a
Constructive Technology Assessment to help decision-making in an
uncertain time of development
Item Type:Article
Faculty:
Management and Governance (SMG)
Research Group:
Link to this item:http://purl.utwente.nl/publications/76772
Official URL:http://www.eahp.eu/EJHP/EJHP-Practice/Issue-6-2008/Update/Establishing-cost-effectiveness-of-genetic-targeting-of-cancer-therapies
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page

Metis ID: 253457